Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06BNK
|
|||
| Drug Name |
Pyrazolo[3,4-d]pyrimidine derivative 5
|
|||
| Synonyms |
PMID27646564-Compound-9
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA MOUNT SINAI SCHOOL OF MEDICINE DAR, Arvin, C. DAS, Tirtha, K. SOS, Martin BIVONA, Trever, G. SHOKAT, Kevan, M. CAGAN, Ross, LUniversity of California and Icahn School of Medicine at Mount Sinai
|
|||
| Structure |
 |
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Proto-oncogene c-Ret (RET) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Proto-oncogene c-Ret (RET) | Target's Patent Info | [1] | |
| KEGG Pathway | Endocytosis | |||
| Pathways in cancer | ||||
| Thyroid cancer | ||||
| Central carbon metabolism in cancer | ||||
| Pathway Interaction Database | Signaling events regulated by Ret tyrosine kinase | |||
| Posttranslational regulation of adherens junction stability and dissassembly | ||||
| WikiPathways | SIDS Susceptibility Pathways | |||
| Dopaminergic Neurogenesis | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | RET kinase inhibitors: a review of recent patents (2012-2015).Expert Opin Ther Pat. 2017 Jan;27(1):91-99. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.